BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21151673)

  • 1. Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill.
    Guida M; Bifulco G; Di Spiezio Sardo A; Scala M; Fernandez LM; Nappi C
    Int J Womens Health; 2010 Aug; 2():279-90. PubMed ID: 21151673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study.
    Briggs P; Serrani M; Vogtländer K; Parke S
    Int J Womens Health; 2016; 8():477-487. PubMed ID: 27695365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM; Martell CW
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol valerate and dienogest: a new approach to oral contraception.
    Kiley JW; Shulman LP
    Int J Womens Health; 2011; 3():281-6. PubMed ID: 21892339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
    Zeun S; Lu M; Uddin A; Zeiler B; Morrison D; Blode H
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.
    Nappi RE; Serrani M; Jensen JT
    Int J Womens Health; 2014; 6():711-8. PubMed ID: 25120376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
    von Schoultz B
    Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest.
    Rafie S; Borgelt L; Koepf ER; Temple-Cooper ME; Lehman KJ
    Int J Womens Health; 2013; 5():313-21. PubMed ID: 23788843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
    Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
    Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
    J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
    Jensen JT
    Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
    Nappi RE
    Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
    Endrikat J; Parke S; Trummer D; Schmidt W; Duijkers I; Klipping C
    Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
    J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception with estradiol valerate and dienogest: adherence to the method.
    Fruzzetti F; Paoletti AM; Fidecicchi T; Posar G; Giannini R; Gambacciani M
    Open Access J Contracept; 2019; 10():1-6. PubMed ID: 31191048
    [No Abstract]   [Full Text] [Related]  

  • 20. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B
    Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.